Glucose-Regulating Drugs Aid COVID-19 Outcomes in Patients With Diabetes
Findings include GLP-1R agonists and pioglitazone use, with drop in hospital admissions.
Diabetes
Emergency Department Visits for Medication Harms Are Frequent
However, most common product type and intent of use associated with these visits vary by age.
Controversies in the Diagnosis and Treatment of Gastroparesis
Researchers addressed common misconceptions regarding the diagnosis and treatment of gastroparesis.
Risk Factors for MACE After First Acute Coronary Syndrome Identified
The risk for recurrent MACE was high among survivors of a first ever acute coronary syndrome with a substantial number of these being fatal; 34.4% had MACE within 1 year and 48.4% in 3 years.
Type 2 Diabetes Remission Criteria Defined in ADA Consensus Statement
People diagnosed with type 2 diabetes can eventually achieve normal glucose levels. But whether or when this means a person is “in remission” was the subject of an international group of experts convened by the American Diabetes Association.
The Potential Dangers of Ketogenic Diets in Kidney Disease
A recent review underscores the possible adverse effects of ketogenic diets including increased risks for heart disease, cancer, diabetes, and kidney stones.
Stat Consult: Gastroparesis
This review provides a concise overview of the incidence, risk factors, pathogenesis, diagnostic criteria, differential diagnosis, and treatment of gastroparesis.
SGLT2 Inhibitors Lead to Favorable Renal, CV Outcomes in Type 2 Diabetes
Using certain glucose inhibitors in people with type 2 diabetes may also have a beneficial effect on renal and cardiovascular health, and weight.
USPSTF Says Start Diabetes Screening at Age 35 for Those Overweight, Obese
Overweight or obese adults should be screened for prediabetes, type 2 diabetes and offered or referred for preventive interventions
Bydureon BCise Approved for Adolescents With Type 2 Diabetes
The expanded approval was based on data from a phase 3 study that evaluated exenatide extended-release in 82 patients aged 10 to 17 years with type 2 diabetes.
- Loading...
Loading...
Next post in Type 2 Diabetes Information Center
Loading... 
Loading...